Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of a Maternal Blood Protein Predictor for Case Finding of Pregnancies At Risk of Preeclampsia At Early Gestation

NCT05131282 is registered in ClinicalTrials.gov with HBI Solutions Inc. as lead sponsor.

NCT NCT05131282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05131282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of a Maternal Blood Protein Predictor for Case Finding of Pregnancies At Risk of Preeclampsia At Early Gestation
Lead sponsor
HBI Solutions Inc.
Phase
Observational
Overall status
Completed
Start date
January 1, 2019
Completion date
June 30, 2024
Enrollment
18,000 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pre-eclampsia, preterm birth